01/07/2025
5:47 PM | Sangamo Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SCHEDULE 13G/A | |
12/30/2024
3:23 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
8:27 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
3:07 PM | Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
3:08 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
11:15 PM | Sangamo Therapeutics (Filer)
| Form EFFECT | |
11/12/2024
3:53 PM | Sangamo Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
12:54 PM | Sangamo Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/28/2024
3:11 PM | Davis Gregory D (Reporting)
Sangamo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/27/2024
3:36 PM | Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:37 PM | Dubois-Stringfellow Nathalie (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SGMO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sangamo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/27/2024
3:37 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:38 PM | Pooler Amy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:38 PM | Sangamo Therapeutics (Issuer)
Willoughby Scott B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
5:40 PM | BIOGEN INC. (Filed by)
Sangamo Therapeutics (Subject)
| Form SC 13G/A | |
08/15/2024
3:34 PM | Sangamo Therapeutics (Issuer)
Willoughby Scott B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:05 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Sangamo Therapeutics (Subject)
| Form SC 13G/A | |
06/13/2024
3:42 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:10 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
4:18 PM | Dubois-Stringfellow Nathalie (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:57 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:00 PM | Pooler Amy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:14 PM | Sangamo Therapeutics (Filer)
| Form ARS | |
03/25/2024
4:04 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
6:55 AM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
6:47 AM | Sangamo Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2024
6:11 PM | BIOGEN INC. (Filed by)
Sangamo Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
11:17 AM | Sangamo Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/06/2024
3:35 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
